Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2023
Silicon-Lattice-Matched Boron-Doped Gallium Phosphide: A Scalable Acousto-Optic PlatformNicholas S Yama, I-Tung Chen, Srivatsa Chakravarthi, et al.The Science of the Total Environment|April 19, 2020
Calcareous organic matter coatings sequester siderophores in alkaline soilsRene M Boiteau, Ravi Kukkadapu, John B Cliff, et al.Rheumatology (Oxford, England)|April 12, 2008
Single-point acupuncture and physiotherapy for the treatment of painful shoulder: a multicentre randomized controlled trialJ Vas, C Ortega, V Olmo, et al.Gastroenterologia Y Hepatologia|May 31, 2006
[Crohn's disease and pregnancy. A descriptive and retrospective study]E Ubiña-Aznar, C De Sola-Earle, R Rivera-Irigoin, et al.BMC Cancer|May 15, 2009
Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignanciesAna M Solares, Agueda Santana, Idania Baladrón, et al.Journal of Pharmaceutical and Biomedical Analysis|December 30, 2014
Bio-analytical method based on MALDI-MS analysis for the quantification of CIGB-300 anti-tumor peptide in human plasmaAnia Cabrales-Rico, Beatriz G de la Torre, Hilda E Garay, et al.Biomedicines|January 21, 2023
CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell ModelGeorge V Pérez, Mauro Rosales, Ailyn C Ramón, et al.Biomedicines|August 6, 2021
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300Mauro Rosales, George V Pérez, Ailyn C Ramón, et al.Science Advances|March 6, 2021
Spontaneous phase segregation of Sr<sub>2</sub>NiO<sub>3</sub> and SrNi<sub>2</sub>O<sub>3</sub> during SrNiO<sub>3</sub> heteroepitaxyLe Wang, Zhenzhong Yang, Xinmao Yin, et al.Journal of Proteome Research|September 1, 2010
Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cellsArielis Rodríguez-Ulloa, Yassel Ramos, Jeovanis Gil, et al.Pageof 14